1 completed. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow ClostraBio Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals CLB101™️, Placebo, Placebo control - Gastrointestinal, Overweight , Obesity | Not applicable | Completed | ClostraBio Inc. | 85 | 2025-10-09 | 2026-08-13 |
Obesity (1) · Overweight (1)
United States (1)
Naoh Craft, MD (1)